334 related articles for article (PubMed ID: 25372737)
1. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
Palioura E; Kandaraki E; Diamanti-Kandarakis E
Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
[TBL] [Abstract][Full Text] [Related]
2. Industrial endocrine disruptors and polycystic ovary syndrome.
Palioura E; Diamanti-Kandarakis E
J Endocrinol Invest; 2013 Dec; 36(11):1105-11. PubMed ID: 24445124
[TBL] [Abstract][Full Text] [Related]
3. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
Rutkowska A; Rachoń D
Gynecol Endocrinol; 2014 Apr; 30(4):260-5. PubMed ID: 24397396
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
Palioura E; Diamanti-Kandarakis E
Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
[TBL] [Abstract][Full Text] [Related]
5. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats.
Yang Z; Shi J; Guo Z; Chen M; Wang C; He C; Zuo Z
Chemosphere; 2019 Sep; 231():151-160. PubMed ID: 31129395
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A and human health: a review of the literature.
Rochester JR
Reprod Toxicol; 2013 Dec; 42():132-55. PubMed ID: 23994667
[TBL] [Abstract][Full Text] [Related]
8. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls.
Akın L; Kendirci M; Narin F; Kurtoglu S; Saraymen R; Kondolot M; Koçak S; Elmali F
Acta Paediatr; 2015 Apr; 104(4):e171-7. PubMed ID: 25469562
[TBL] [Abstract][Full Text] [Related]
9. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review.
Merlo E; Silva IV; Cardoso RC; Graceli JB
J Toxicol Environ Health B Crit Rev; 2018; 21(3):181-206. PubMed ID: 30015594
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and environmental toxins.
Rutkowska AZ; Diamanti-Kandarakis E
Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes and enviromental factors: their influence in PCOS.
Diamanti-Kandarakis E; Christakou C; Marinakis E
Curr Pharm Des; 2012; 18(3):270-82. PubMed ID: 22229564
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?
Barrett ES; Sobolewski M
Semin Reprod Med; 2014 May; 32(3):166-76. PubMed ID: 24715511
[TBL] [Abstract][Full Text] [Related]
13. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
Endocr Rev; 2015 Dec; 36(6):593-602. PubMed ID: 26414233
[TBL] [Abstract][Full Text] [Related]
14. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].
Li TT; Xu LZ; Chen YH; Deng HM; Liang CY; Liu Y; Liu XF; Zhang J; Kang DY; Qiu DS; Han DW; Hu R
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1753-6. PubMed ID: 22027783
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol A: an endocrine and metabolic disruptor.
Fenichel P; Chevalier N; Brucker-Davis F
Ann Endocrinol (Paris); 2013 Jul; 74(3):211-20. PubMed ID: 23796010
[TBL] [Abstract][Full Text] [Related]
16. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome.
Akgül S; Sur Ü; Düzçeker Y; Balcı A; Kızılkan MP; Kanbur N; Bozdağ G; Erkekoğlu P; Gümüş E; Kocer-Gumusel B; Derman O
Gynecol Endocrinol; 2019 Dec; 35(12):1084-1087. PubMed ID: 31219355
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine disruption in animal models due to exposure to bisphenol A analogues.
Rosenfeld CS
Front Neuroendocrinol; 2017 Oct; 47():123-133. PubMed ID: 28801100
[TBL] [Abstract][Full Text] [Related]
18. Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats.
Patisaul HB; Mabrey N; Adewale HB; Sullivan AW
Reprod Toxicol; 2014 Nov; 49():209-18. PubMed ID: 25242113
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine disruptors and obesity: obesogens].
García-Mayor RV; Larrañaga Vidal A; Docet Caamaño MF; Lafuente Giménez A
Endocrinol Nutr; 2012 Apr; 59(4):261-7. PubMed ID: 22300604
[TBL] [Abstract][Full Text] [Related]
20. Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.
Jozkowiak M; Piotrowska-Kempisty H; Kobylarek D; Gorska N; Mozdziak P; Kempisty B; Rachon D; Spaczynski RZ
Cells; 2022 Dec; 12(1):. PubMed ID: 36611967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
